¸£ÀûÔÚÏßÃâ·Ñ

The Malta Association of Biomedical Scientists (MABS) is going to hold its first ever hybrid conference. The National Biomedical Laboratory Science Conference, 'At the Crossroads of Research and Laboratory Medicine’. It will be held on 2 and 3 May, 2022. For this hybrid conference, attendees will be able to join either via our online platform as well as in person. The event will be open for all healthcare professionals, researchers and students.

The Malta Association of Biomedical Scientists is an autonomous, non-profit organisation, concerned with all matters related to the science of pathology. It is a body of science professionals who foster and advocate excellence in the practice, education and management of Medical Laboratory Sciences.

Abstracts for oral and poster presentations are invited on any of the following specialties of Applied Biomedical Science; microbiology, haematology, biochemistry, histopathology and cytology, genetics, blood transfusion medicine and immunology and related disciplines. 

The invitation is open to all Biomedical Scientists and other medical professionals including undergraduate and post-graduate students.

The deadline for abstract submission is 6 March 2022. Preparation and submission of abstracts should follow the Abstract Submission Guidelines.

Abstract Submission Guidelines 

MABS is welcoming three abstract categories: a) Research study b) Case study and c) General topic

Each abstract should not exceed 300 words.

a) Research study abstracts should be in line with the following guidelines:
(i) indicate the specific purpose of the study
(ii) describe the methodology used to achieve the purpose, specifying sample size
(iii) present the key findings with supporting evidence
(iv) present the conclusions based on the data provided
(v) highlight the novelty of the work.

b) Case study abstracts should be in line with the following guidelines:
(i) present the clinical background
(ii) describe the methodology used to study the case
(iii) present the key findings
(iv) highlight the conclusions and learning outcomes from the case study
Interdisciplinary case studies will be given preference.

c) General topic abstracts will also be considered. Topics may include novel technologies or techniques, new frontiers and emerging fields related to Biomedical Science. Abstracts should include an overview of the proposed topic highlighting why the topic is of interest and cutting-edge.

Abstracts should not include references, figures or tables. All abbreviations should be defined when they appear in the text for the first time. Abstracts should be edited carefully and thoroughly before submission. Funding support declarations may be included and should not be considered in the word count.

Abstracts should be submitted through this  by 6 March, 2022 at 23:59 (GMT+1). 

Researcher(s) details should not appear on the Abstract field.

All submitted abstracts will be reviewed by the MABS Scientific Committee. 

Abstracts will be evaluated according to their scientific/clinical merit and in line with the scope of the MABS Conference. General topic abstracts will be evaluated based on their educational value and innovation.

Authors of abstracts selected for oral presentation will be informed about the session, date of presentation, and presentation guidelines will be provided. Authors presenting a poster will be informed about the date of the poster session and will receive guidelines for preparation and presentation.

All accepted abstracts will appear in a special online version of MABS Conference Abstracts on the MABS website. In submitting an abstract, authors are consenting to its inclusion in these publications.

For an accepted abstract to be included in the final scientific programme it is mandatory for the presenting author to register attendance for the conference.